This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ednie, L. M.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ednie, L. M.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 05 1997, 1037-1041, Vol 41, No. 5
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole

LM Ednie, SK Spangler, MR Jacobs and PC Appelbaum
Department of Pathology (Clinical Microbiology), Hershey Medical Center, Pennsylvania 17033, USA.

Agar dilution methodology (with added Oxyrase in the case of the macrolide group to allow incubation without added CO2) was used to compare the activity of RU 64004, a new ketolide, with the activities of erythromycin, azithromycin, clarithromycin, roxithromycin, clindamycin, amoxicillin with and without clavulanate, piperacillin with and without tazobactam, metronidazole, and imipenem against 379 anaerobes. Overall, RU 64004 yielded an MIC at which 50% of the isolates are inhibited (MIC50) of 1.0 microg/ml and an MIC90 of 16.0 microg/ml. In comparison, MIC50s and MIC90s of erythromycin, azithromycin, clarithromycin, and roxithromycin were 2.0 to 8.0 and >64.0 microg/ml, respectively. MICs of macrolides, including RU 64004, were higher for Bacteroides ovatus, Fusobacterium varium, Fusobacterium mortiferum, and Clostridium difficile than for the other species. RU 64004 was more active against gram-positive rods and cocci, Prevotella and Porphyromonas spp., and fusobacteria other than F. mortiferum and F. varium than against the Bacteroides fragilis group. Overall MIC50s and MIC90s (in micrograms per milliliter), respectively, of other compounds were as follows: clindamycin, 1.0 and 16.0; amoxicillin, 4.0 and 64.0; amoxicillin-clavulanate, 0.5 and 4.0; piperacillin, 8.0 and >64.0; piperacillin-tazobactam, 1.0 and 16.0; metronidazole, 1.0 and 4.0; and imipenem, 0.25 and 1.0.


This article has been cited by other articles:

  • Vester, B., Douthwaite, S. (2001). Macrolide Resistance Conferred by Base Substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45: 1-12 [Full Text]  
  • Bemer-Melchior, P., Juvin, M.-E., Tassin, S., Bryskier, A., Schito, G. C., Drugeon, H.-B. (2000). In Vitro Activity of the New Ketolide Telithromycin Compared with Those of Macrolides against Streptococcus pyogenes: Influences of Resistance Mechanisms and Methodological Factors. Antimicrob. Agents Chemother. 44: 2999-3002 [Abstract] [Full Text]  
  • Baltch, A. L., Smith, R. P., Ritz, W. J., Franke, M. A., Michelsen, P. B. (2000). Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila. J Antimicrob Chemother 46: 51-55 [Abstract] [Full Text]  
  • Jung, R., Messick, C. R., Pendland, S. L., Tesoro, E. P., Losendahl, K. J., Schriever, C. A., Danziger, L. H. (2000). Postantibiotic Effects and Bactericidal Activities of Clarithromycin-14-Hydroxy-Clarithromycin, versus Those of Amoxicillin-Clavulanate, against Anaerobes. Antimicrob. Agents Chemother. 44: 778-779 [Abstract] [Full Text]  
  • Schaumann, R., Ackermann, G., Pless, B., Claros, M. C., Rodloff, A. C. (1999). In Vitro Activities of Gatifloxacin, Two Other Quinolones, and Five Nonquinolone Antimicrobials against Obligately Anaerobic Bacteria. Antimicrob. Agents Chemother. 43: 2783-2786 [Abstract] [Full Text]  
  • Edelstein, P. H., Edelstein, M. A. C. (1999). In Vitro Activity of the Ketolide HMR 3647 (RU 6647) for Legionella spp., Its Pharmacokinetics in Guinea Pigs, and Use of the Drug To Treat Guinea Pigs with Legionella pneumophila Pneumonia. Antimicrob. Agents Chemother. 43: 90-95 [Abstract] [Full Text]  
  • Rosato, A., Vicarini, H., Bonnefoy, A., Chantot, J.-F., Leclercq, R. (1998). A New Ketolide, HMR 3004, Active against Streptococci Inducibly Resistant to Erythromycin. Antimicrob. Agents Chemother. 42: 1392-1396 [Abstract] [Full Text]  
  • Soriano, F., Fernández-Roblas, R., Calvo, R., García-Calvo, G. (1998). In Vitro Susceptibilities of Aerobic and Facultative Non-Spore-Forming Gram-Positive Bacilli to HMR 3647 (RU 66647) and 14 Other Antimicrobials. Antimicrob. Agents Chemother. 42: 1028-1033 [Abstract] [Full Text]  
  • Goldstein, E. J. C., Citron, D. M., Gerardo, S. H., Hudspeth, M., Merriam, C. V. (1998). Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) Compared to Those of Erythromycin, Azithromycin, Clarithromycin, Roxithromycin, and Eight Other Antimicrobial Agents against Unusual Aerobic and Anaerobic Human and Animal Bite Pathogens Isolated from Skin and Soft Tissue Infections in Humans. Antimicrob. Agents Chemother. 42: 1127-1132 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»